All News

Maralixibat (Livmarli) is an ileal bile acid transporter inhibitor indicated for the treatment of cholestatic pruritus in patients with Alagille syndrome 1 year of age and older.

Equate may help to prevent nausea and dizziness due to motion sickness for up to 24 hours.

With the FDA approval and launch of the first interchangeable biosimilar in the United States in 2021, retail pharmacists are poised to play an increasing role in the future uptake of biosimilars.

Study results show at a molecular level how fidaxomicin selectively targets these bacteria, while sparing others in the gut microbiome.

Study results show that an individual received little or no relief from doing yoga, eliminating certain foods, practicing medication, or taking prescribed medications.

Getting an appointment with an infectious diseases specialist, particularly after giving birth and while managing a chronic disorder, such as substance use, is difficult, investigators say.

Strong support from pharmacy professionals and a shift in systems and workflows help pave the way for success.

Pharmacy Quality Alliance's new benchmark evaluates adherence to medications for diabetes, high cholesterol, and hypertension.

Cutaneous squamous cell carcinoma should be diagnosed early and treated promptly to avoid complications.

A multidisciplinary team of nurse practitioners and pharmacists can work together to address patients at an increased risk for hospital readmission.

In studies of rats, results show that supplementation preserves skeletal muscle after patients take the chemotherapy medication doxorubicin.

Breztri is indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease.

Magnesium helps with nerve support, healthy bones, and heart function improvement.

A variety of strategies can help increase patient adherence to oral chemotherapy.

Each vaccine candidate includes 8 mRNAs, which targets both hemagglutinin and neuraminidase at different doses and ratios.

Peptide-targeted radionuclide therapy FAP-2286 (Clovis Oncology) showed potent affinity for human fibroblast activation protein by biochemical and cell-based assays.

In a clinical trial, 86.4% of patients on semaglutide achieved a 5% weight loss at week 68 compared to 31.5% with placebo.

Technology clears the way to offer clinical-focused tasks, ultimately improving job satisfaction and minimizing burnout.

Inflammatory bowel disease has complex treatment options, but pharmacists can help patients make the right choice.

Genome sequencing shows the clonality of outbreak isolates within each of 6 classes, which confirmed that recent transmissions accounted for high carriage.

The pharmacist's role in the profession has immensely changed since the COVID-19 pandemic, and it will continue to change with new initiatives for the future and the integration of more public health policies.

Betrixaban (Bevyxxa) is a factor Xa inhibitor indicated for the prophylaxis of venous thromboembolism in adult patients.

Move Free is intended to support joint health and help with osteoarthritis pain.

On average, patients visit their community pharmacist 12 times more often than they do their primary care provider

Obesity and a limited physical activity are key factors in post-COVID-19 recovery.

Phase 3 REST-ON Trial data show that the medication demonstrated clinically meaningful improvement in assessments of disrupted nighttime sleep compared with the placebo.

Suzanne Soliman, PharmD, welcomed back guests Christina Madison, PharmD, FCCP, AAHIVP, and Joanna Lewis, PharmD.

Those hospitalized for COVID-19 were 21% more likely to develop shingles.